152 results on '"Kamato, Danielle"'
Search Results
2. Response to retention hypothesis as a source of targets for arterial wall-directed therapies to prevent atherosclerosis: A critical review
3. Mechanistic insight: Linking cardiovascular complications of inflammatory bowel disease
4. Moscatilin inhibits vascular calcification by activating IL13RA2-dependent inhibition of STAT3 and attenuating the WNT3/β-catenin signalling pathway
5. Endothelin-1 mediated glycosaminoglycan synthesizing gene expression involves NOX-dependent transactivation of the transforming growth factor-β receptor
6. PAR2 activation on human tubular epithelial cells engages converging signaling pathways to induce an inflammatory and fibrotic milieu.
7. Lipopolysaccharide acting via toll-like receptor 4 transactivates the TGF-β receptor in vascular smooth muscle cells
8. Smad2 linker region phosphorylation is an autonomous cell signalling pathway: Implications for multiple disease pathologies
9. Smad linker region phosphorylation is a signalling pathway in its own right and not only a modulator of canonical TGF-β signalling
10. Mechanisms of PAR-1 mediated kinase receptor transactivation: Smad linker region phosphorylation
11. Targeted Molecular Imaging of Cardiovascular Diseases by Iron Oxide Nanoparticles
12. G protein coupled receptors can transduce signals through carboxy terminal and linker region phosphorylation of Smad transcription factors
13. Transforming growth factor–β1 mediated CHST11 and CHSY1 mRNA expression is ROS dependent in vascular smooth muscle cells
14. Insights into cellular signalling by G protein coupled receptor transactivation of cell surface protein kinase receptors
15. Gaq proteins: molecular pharmacology and therapeutic potential
16. 25 Years of endothelin research: the next generation
17. Evaluation of the potential synergism of imatinib-related poly kinase inhibitors using growth factor stimulated proteoglycan synthesis as a model response
18. Gαq Is the Specific Mediator of PAR-1 Transactivation of Kinase Receptors in Vascular Smooth Muscle Cells.
19. Non-Mouse Models of Atherosclerosis: Approaches to Exploring the Translational Potential of New Therapies.
20. Peptidyl-prolyl isomerases: Functionality and potential therapeutic targets in cardiovascular disease
21. Endothelin‐1 dependent expression of GAG genes involves NOX and p38 mediated Smad linker region phosphorylation.
22. Transforming growth factor β-mediated site-specific Smad linker region phosphorylation in vascular endothelial cells
23. Akt acts as a switch for GPCR transactivation of the TGF‐β receptor type 1.
24. Suramin inhibits PDGF-stimulated receptor phosphorylation, proteoglycan synthesis and glycosaminoglycan hyperelongation in human vascular smooth muscle cells
25. (S)-[6]-Gingerol inhibits TGF-β-stimulated biglycan synthesis but not glycosaminoglycan hyperelongation in human vascular smooth muscle cells
26. Therapeutic implications of endothelin and thrombin G-protein-coupled receptor transactivation of tyrosine and serine/threonine kinase cell surface receptors
27. YY‐11, a camel milk‐derived peptide, inhibits TGF‐β‐mediated atherogenic signaling in human vascular smooth muscle cells.
28. Cell biology of Smad2/3 linker region phosphorylation in vascular smooth muscle
29. GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential.
30. Impact of sodium glucose cotransporter 2 (SGLT2) inhibitors on atherosclerosis: from pharmacology to pre-clinical and clinical therapeutics.
31. Targeted Molecular Imaging of Cardiovascular Diseases by Iron Oxide Nanoparticles.
32. Treatment of atherosclerotic plaque: perspectives on theranostics.
33. Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics.
34. Individual Smad2 linker region phosphorylation sites determine the expression of proteoglycan and glycosaminoglycan synthesizing genes.
35. Activatable magnetic resonance nanosensor as a potential imaging agent for detecting and discriminating thrombosis.
36. Thrombin promotes PAI-1 expression and migration in keratinocytes via ERK dependent Smad linker region phosphorylation.
37. RNA sequencing to determine the contribution of kinase receptor transactivation to G protein coupled receptor signalling in vascular smooth muscle cells.
38. Endothelin-1 (ET-1) stimulates carboxy terminal Smad2 phosphorylation in vascular endothelial cells by a mechanism dependent on ET receptors and de novo protein synthesis.
39. The role of specific Smad linker region phosphorylation in TGF-β mediated expression of glycosaminoglycan synthesizing enzymes in vascular smooth muscle.
40. Protease activated receptor-1 mediated dual kinase receptor transactivation stimulates the expression of glycosaminoglycan synthesizing genes.
41. The expansion of GPCR transactivation-dependent signalling to include serine/threonine kinase receptors represents a new cell signalling frontier.
42. Atherogenic, fibrotic and glucose utilising actions of glucokinase activators on vascular endothelium and smooth muscle.
43. Transforming growth factor-β signalling: Role and consequences of Smad linker region phosphorylation.
44. Endothelin receptor transactivates the TGFβ receptor to stimulate proteoglycan synthesis in human vascular smooth muscle cells
45. Endothelial Dysfunction and Cardiovascular Disease: History and Analysis of the Clinical Utility of the Relationship.
46. Curcumin Inhibits Lysophosphatidic Acid Mediated MCP-1 Expression via Blocking ROCK Signalling.
47. Mouse models of atherosclerosis in translational research.
48. Artemisinin inhibits glycosaminoglycan chain synthesizing gene expression but not proliferation of human vascular smooth muscle cells.
49. Endothelial function and dysfunction: Impact of metformin.
50. Signalling pathways regulating galactosaminoglycan synthesis and structure in vascular smooth muscle: Implications for lipoprotein binding and atherosclerosis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.